Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Spur cell anaemia
ADR ID BADD_A10964
ADR Hierarchy
01      Blood and lymphatic system disorders
01.06      Haemolyses and related conditions
01.06.05      Red cell membrane and enzyme abnormalities
01.06.05.003      Spur cell anaemia
Description An autosomal recessive disorder of lipid metabolism. It is caused by mutation of the microsomal triglyceride transfer protein that catalyzes the transport of lipids (TRIGLYCERIDES; CHOLESTEROL ESTERS; PHOSPHOLIPIDS) and is required in the secretion of BETA-LIPOPROTEINS (low density lipoproteins or LDL). Features include defective intestinal lipid absorption, very low serum cholesterol level, and near absent LDL. [MeSH]
MedDRA Code 10052483
MeSH ID D000012
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Spur cell anaemia | Spur cell anemia | Acanthocytosis | Abetalipoproteinemia | Bassen-Kornzweig Disease | Bassen Kornzweig Disease | Microsomal Triglyceride Transfer Protein Deficiency Disease | Betalipoprotein Deficiency Disease | Betalipoprotein Deficiency Diseases | Deficiency Disease, Betalipoprotein | Deficiency Diseases, Betalipoprotein | Disease, Betalipoprotein Deficiency | Diseases, Betalipoprotein Deficiency | Microsomal Triglyceride Transfer Protein Deficiency | Acanthocytoses | Bassen-Kornzweig Syndrome | Bassen Kornzweig Syndrome
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02480Alectinib0.000336%
The 1th Page    1    Total 1 Pages